pharma
dog
News
when
Latest
Archive
by source
All Sources
Sources Page
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
Drugs
by stage
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
browse
Most catalysts
Recently active
All drugs →
Companies
Patent cliff
Calendar
what
Trial readouts
PDUFA dates
Approvals
Earnings
when
Upcoming
Month grid
Recently passed
◐
Sign In
Subscribe
home
jobs
news
search
the cabinet
Drugs
6,918
products tracked ·
6,918
matching
★ save view
↓
export CSV
search
phase
all
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
sort
catalysts
recent
name
therapeutic area
all
Oncology
1831
Infectious Disease
718
Cardiology
425
Pulmonology
396
Immunology
371
Ophthalmology
368
Dermatology
300
Women's Health
view
list
cards
Phase 2
ELI-002 2P
Colorectal Cancer
$ELTX
Elicio Therapeutics, Inc.
ELLIOTTS B
ELLIOTTS B (SODIUM CATION, SODIUM BICARBONATE, ANHYDROUS DEXTROSE, MAGNESIUM SULFATE, POTASSIUM CHLORIDE, CALCIUM CHLORIDE, SODIUM PHOSPHATE)
no indication
LUKARE MEDICAL LLC
ELTROMBOPAG
ELTROMBOPAG
no indication
ZYDUS PHARMS
Phase 2
ELU-42
← prev
page 81 of 231
next →
131
Pain
89
Neurology
1
Diabetic Foot Ulcers
Eluciderm Inc
ELURYNG
ELURYNG (ETONOGESTREL AND ETHINYL ESTRADIOL)
no indication
AMNEAL
Phase 1
ELVN-001
Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia)
$ELVN
Enliven Therapeutics, Inc.
Phase 2
ELVN-002
Human Epidermal Growth Factor Receptor 2 Positive Breast…
$ELVN
Enliven Therapeutics, Inc.
Preclinical
EMD-101
Neutropenia
EmendoBio Inc
Preclinical
EMD-202
Retinitis Pigmentosa (Retinitis)
EmendoBio Inc
EMROSI
EMROSI (MINOCYCLINE HYDROCHLORIDE EXTENDED-RELEASE)
no indication
JOURNEY
EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE
EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE
no indication
CHARTWELL RX
Phase 2
EN-374
Chronic Granulomatous Disease
Ensoma Inc
ENALAPRIL MALEATE ORAL SOLUTION
ENALAPRIL MALEATE ORAL SOLUTION
no indication
ALKEM LABS LTD
Phase 2
ENB-003
Pancreatic Cancer
ENB Therapeutics LLC
Phase 3
ENB-106
Diabetic Retinopathy
Ennovabio
Phase 3
ENERGIF-703
Diabetic Foot Ulcers
Energenesis Biomedical Co Ltd
Phase 1
ENS-002
Atopic Dermatitis (Atopic Eczema)
Concerto Biosciences Inc
Phase 1
ENV-308
Obesity
Enveda Biosciences Inc
Phase 1
ENV-6946
Inflammatory Bowel Disease
Enveda Biosciences Inc
Phase 1
EO-2002
Corneal Edema
Emmecell LLC
Phase 2
EO-2463
Extranodal Marginal Zone B-Cell Lymphoma (Mucosa-Associat…
Enterome Bioscience SA
EOVIST
EOVIST (GADOXETATE DISODIUM)
no indication
BAYER HLTHCARE
Preclinical
EP-055
Male Contraception
Eppin Pharma Inc
Phase 2
EPI-321
Facioscapulohumeral Muscular Dystrophy (FSHD)
Epicrispr Biotechnologies Inc
EPIOXA CROSS-LINKING
EPIOXA CROSS-LINKING (RIBOFLAVIN 5-PHOSPHATE OPHTHALMIC)
no indication
GLAUKOS
Preclinical
EPM-301
Prader-Willi Syndrome (PWS)
EPM Group Inc
Preclinical
EPS-401
Non-Small Cell Lung Cancer
Epsilogen Ltd
Preclinical
EPV-002
Substance (Drug) Abuse
EpiVario Inc
EQUATE OMEPRAZOLE AND SODIUM BICARBONATE
EQUATE OMEPRAZOLE AND SODIUM BICARBONATE (OMEPRAZOLE, SODIUM BICARBONATE)
no indication
PERRIGO R AND D
Phase 1
ER-100
Non-Arteritic Anterior Ischemic Optic Neuropathy
Life Biosciences Inc.